Effect of total flavonoids in Apocynum venetum leaves on rat hypertension induced by high fat and high salt and its molecular mechanism

Chinese Traditional and Herbal Drugs

Volumn 43, Issue 3, 2012, Pages 540-545

  Li, Zhi ^a,b   Wang, Chao Yun ^a   Zhang, Shu Ping ^a   Wang, Jun Lian ^a   Zhang, Xiao Min ^a   He, Qian Qian ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Blood lipid; CRP; Lower blood pressure; TGF 1; Total flavonoids from Apocynum venetum L. leaves (TFA)

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOCYNUM VENETUM EXTRACT; C REACTIVE PROTEIN; CHINESE DRUG; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUOBUMA; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; APOCYNUM; APOCYNUM VENETUM; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; HIGH SODIUM INTAKE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIPID DIET; LOW DRUG DOSE; MALE; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; RAT; SPECTROPHOTOMETRY; VASCULAR TISSUE; WESTERN BLOTTING;

EID: 84859256260     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Willerson J T, Ridker P M. Inflammation as a cardiovascular risk factor [J]. Circulation, 2004, 109 (21 Suppl 1): II2-II10.
2. Devaraj S, Siegel D, Jialal I. Statin therapy in metabolic syndrome and hypertension post-JUPITER: What is the value of CRP [J]. Curr Atheroscler Rep, 2011, 13 (1): 31-42.
3. Soundararajan R, Pearce D, Hughey R P, et al. Role of epithelial sodium channels and their regulators in hypertension [J]. J Biol Chem, 2010, 285 (40): 30363-30369.
4. Sanders P W. Vascular consequences of dietary salt intake [J]. Am J Physiol Renal Physiol, 2009, 297 (2): F237-F243.
5. 2008, 31 (5): 784-787.
6. 2006, 27 (4): 41-49.
7. 2005, 24 (6): 21-25.
8. Montenegro M F, Neto-Neves E M, Dias-Junior C A, et al. Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension [J]. Naunyn Schmiedebergs Arch Pharmacol, 2010, 382 (4): 293-301.
9. Perez-Vizcaino F, Duarte J, Jimenez R, et al. Anti-hypertensive effects of the flavonoid quercetin [J]. Pharmacol Rep, 2009, 61 (1): 67-75.
10. Mackraj I, Govender T, Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension [J]. J Cardiovasc Pharmacol, 2008, 51 (3): 239-245.
11. 2006, 37 (10): 9-11.
12. Leibowitz A, Schiffrin E L. Immune mechanisms in hypertension [J]. Curr Hypertens Rep, 2011, 13 (6): 465-472.
13. Bonora E. The metabolic syndrome and cardiovascular disease [J]. Ann Med, 2006, 38 (1): 64-80.
14. Zambon A, Pauletto P, Crepaldi G. Review article: The metabolic syndrome-a chronic cardiovascular inflam-matory condition [J]. Aliment Pharmacol Ther, 2005, 22 (Suppl 2): 20-23.
15. Abd T T, Eapen D J, Bajpai A, et al. The role of C-reactive protein as a risk predictor of coronary atherosclerosis: Implications from the JUPITER trial [J]. Curr Atheroscler Rep, 2011, 13 (2): 154-161.
16. Kuklinska A M, Mroczko B, Musial W J, et al. High-sensitivity C-reactive protein and total antioxidant status in patients with essential arterial hypertension and dyslipidemia [J]. Adv Med Sci, 2009, 54 (2): 225-232.
17. Virdis A, Ghiadoni L, Plantinga Y, et al. C-reactive protein and hypertension: Is there a causal relationship? [J]. Curr Pharm Des, 2007, 13 (16): 1693-1698.
18. Ridker P M, Silvertown J D. Inflammation, C-reactive protein, and atherothrombosis [J]. J Periodontol, 2008, 79 (8 Suppl): 1544-1551.
19. Venugopal S K, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: Evidence for a proinflammatory, proatherogenic role [J]. Curr Opin Nephrol Hypertens, 2005, 14 (1): 33-37.
20. Yeh E T, Anderson H V, Passeri V, et al. C-reactive protein linking inflammation to cardiovascular complica-tions [J]. Circulation, 2001, 104 (4): 974-975.
21. August P, Leventhal B, Suthanthiran M. Hypertension-induced organ damage in African Americans: Transforming growth factor-beta (1) excess as a mechanism for increased prevalence [J]. Curr Hypertens Rep, 2000, 2 (2): 184-191.
22. Sanders P W. Vascular consequences of dietary salt intake [J]. Am J Physiol Renal Physiol, 2009, 297 (2): F237-F243.
23. Bhatt K N, Wells B J, Sperling L S, et al. High-density lipoprotein therapy: Is there hope? [J]. Curr Treat Options Cardiovasc Med, 2010, 12 (4): 315-328.
24. Hoki S, Kmura T, Nagasawa M, et al. Antihypertensive effects of the principal flavonoids of YANLONG tea in spontaneously hypertensive rats [J]. Nat Med, 2004, 58 (3): 113-116.
25. 1999, 21 (1): 53-54.